Total Health

 

Total Health is the largest provider of free cancer care resources for people who are treating or living with cancer. Our programs arm cancer care teams with the latest research and strategies to improve patient outcomes.

For more info visit our website at Total Health.

 

2021 Virtual Best of Breast
K

Combatting Endocrine Resistance in BC: Use of Integrated Medicine Approaches, Epigenetics

By 2021 Virtual Best of Breast FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
By 2021 Virtual Best of Breast FEATURING Kelly Hunt, Reshma L. Mahtani, Elisa Krill-Jackson, Mike Cusnir, Lisa Hineman
36 views
January 25, 2021
0 Comments
Login to view comments. Click here to Login

Featured Video

06:51
Insights from 2023 ASH Annual Meeting

ASH 2023 Insights: "Prevalence and Prediction of Ruxolitinib Tr…

Feat. D. Tremblay

Featured Video

20:09
AstraZeneca Oncology

Management Strategies for Anemia in First-line Maintenance Therapy f…

Feat. D. Czel, C. Arn
2021 Virtual Best of Breast
16:02
2021 Virtual Best of Breast

Case Study of Premenopausal Woman With HR+, HER2- MBC: What Does the…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
08:26
2021 Virtual Best of Breast

HR+/HER2- MBC: What Are the Biopsy and 1L Treatment Options Using NC…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
14:15
2021 Virtual Best of Breast

Breast Cancer Genetic Testing: What Are the Most Common Mutations? W…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
15:59
2021 Virtual Best of Breast

Optimizing Genetic Testing for BC: Who & When Should Get Tested?

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
17:37
2021 Virtual Best of Breast

PARPi for BC With Germline Mutations: Why Are They Good Option for B…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
08:46
2021 Virtual Best of Breast

BC Risk Management: Should We Be Offering Testing to Everyone? Do We…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
13:34
2021 Virtual Best of Breast

BC Cascade Testing: How Can Patients Use Testing to Inform Their Fam…

Feat. W. Chung, J. Klemp, J. Meisel, M. Yepes
06:14
2021 Virtual Best of Breast

Combatting Endocrine Resistance in BC: Use of Integrated Medicine Ap…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
19:31
2021 Virtual Best of Breast

Endocrine Decision Making in BC: OFS+Tamoxifen/Exemestane - What Pro…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
06:18
2021 Virtual Best of Breast

40 y/o Premenopausal Woman With mBC: Does LRT for the IPT Show Survi…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
09:19
2021 Virtual Best of Breast

BC Side Effects: What Are the Key Points That Need to Be Assessed at…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
07:34
2021 Virtual Best of Breast

Postmenopausal Woman With Triple-Positive Breast Cancer: How to Appr…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
22:46
2021 Virtual Best of Breast

56 y/o Postmenopausal Woman With Triple-Positive BC: Estrogen Depriv…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
10:46
2021 Virtual Best of Breast

BC Side Effects & Survivorship: What Are the Most Common AI-Rela…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
13:24
2021 Virtual Best of Breast

BC & Menopause Side Effects: Cardio-Toxicity, Cardiac Sparing Ra…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
06:12
2021 Virtual Best of Breast

BC Side Effects: Cost of Cancer Care - Determinants, Effects & B…

Feat. J. Klemp, K. Mirabeau-Beale, K. Rojas, M. Lima
12:07
2021 Virtual Best of Breast

40 y/o Premenopausal Woman With Palpable Right Breast Mass: Should W…

Feat. K. Hunt, R. L. Mahtani, E. Krill-Jackson, M. Cusnir, L. Hineman
21:39
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Is IDFS Better With ET Alone o…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
21:08
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Does PMRT After ALND Reduce th…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
09:37
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Does OFS+Exemestane Improve DR…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
14:59
2021 Virtual Best of Breast

36 y/o Pre-Menopausal Woman With EBC: Can Tamoxifen Reduce Mortality…

Feat. L. Freedman, K. Kalinsky, T. Mamounas, L. Nye
21:20
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Genetic Counseling/Testing, Bilateral Breas…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
14:28
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Can We Achieve pCR With Pembro/Atezo? What …

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
07:08
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: What Is the FNR of SLN Surgery After Chemo?…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
03:22
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Does Adjuvant Capecitabine Improve DFS Afte…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
10:19
2021 Virtual Best of Breast

55 y/o Woman With mTNBC: Is Atezo+Nab-Paclitaxel Beneficial for PFS/…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
09:43
2021 Virtual Best of Breast

2021 Update on New Agents for mTNBC: ADCs (Sacituzumab Govitecan, La…

Feat. A. Amin, E. Krill-Jackson, K. Kalinsky, M. Press
09:00
2021 Virtual Best of Breast

59 y/o Woman With HER2+ Invasive Ductal Carcinoma: Is Neoadjuvant Tr…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani
12:44
2021 Virtual Best of Breast

59 y/o Woman With HER2+ EBC: Should We Choose T-DM1 as Post-Neoadjuv…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani
11:19
2021 Virtual Best of Breast

HER2+ mBC Case Study Discussion: PFS Data of Tucatinib + Trastuzumab…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani
22:37
2021 Virtual Best of Breast

Case Study Discussion on HER2+ MBC: Trastuzumab Deruxtecan in Heavil…

Feat. P. Anderson, S. Badve, E. Hamilton, R. L. Mahtani